Inhibition of T-Cell activation by the CTLA4-Fc abatacept is sufficient to ameliorate proteinuric kidney disease

  1. Herrera, M.
  2. Söderberg, M.
  3. Sabirsh, A.
  4. Valastro, B.
  5. Mölne, J.
  6. Santamaria, B.
  7. Valverde, A.M.
  8. Guionaud, S.
  9. Heasman, S.
  10. Bigley, A.
  11. Jermutus, L.
  12. Rondinone, C.
  13. Coghlan, M.
  14. Baker, D.
  15. Quinn, C.M.
Aldizkaria:
American Journal of Physiology - Renal Physiology

ISSN: 1522-1466,  0363-6127

Argitalpen urtea: 2017

Alea: 312

Zenbakia: 4

Orrialdeak: F748-F759

Mota: Artikulua

DOI: 10.1152/AJPRENAL.00179.2016 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus